CARLOS
SOLANO VERCET
CATEDRÁTICO/A DE UNIVERSIDAD
Instituto de Salud Carlos III
Madrid, EspañaPublicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (19)
2021
-
Allogeneic hematopoietic stem cell transplant recipients in Spain: Human leukocyte antigen characteristics and diversity by high-resolution analysis
HLA, Vol. 97, Núm. 3, pp. 198-213
-
Assessment of the association between cytomegalovirus DNAemia and subsequent acute graft-versus-host disease in allogeneic peripheral blood stem cell transplantation: A multicenter study from the Spanish hematopoietic transplantation and cell therapy group
Transplant Infectious Disease, Vol. 23, Núm. 4
-
CAR-T therapy in solid transplant recipients with post-transplant lymphoproliferative disease: case report and literature review
Current Research in Translational Medicine
-
Cytomegalovirus DNAemia and risk of mortality in allogeneic hematopoietic stem cell transplantation: Analysis from the Spanish Hematopoietic Transplantation and Cell Therapy Group
American Journal of Transplantation, Vol. 21, Núm. 1, pp. 258-271
-
Ex vivo T-cell depletion vs post-transplant cyclophosphamide, sirolimus, and mycophenolate mofetil as graft-vs-host disease prophylaxis for allogeneic hematopoietic stem cell transplantation
European Journal of Haematology, Vol. 106, Núm. 1, pp. 114-125
2020
-
Assessment of immunodeficiency scoring index performance in enterovirus/rhinovirus respiratory infection after allogeneic hematopoietic stem cell transplantation
Transplant Infectious Disease, Vol. 22, Núm. 4
-
Predicting Mortality after Autologous Transplant: Development of a Novel Risk Score
Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 10, pp. 1828-1832
-
Prospective Randomized Study Comparing Myeloablative Unrelated Umbilical Cord Blood Transplantation versus HLA-Haploidentical Related Stem Cell Transplantation for Adults with Hematologic Malignancies
Biology of Blood and Marrow Transplantation, Vol. 26, Núm. 2, pp. 358-366
-
Risk factors and outcome of COVID-19 in patients with hematological malignancies
Experimental Hematology and Oncology, Vol. 9, Núm. 1
-
The effect of timing on community acquired respiratory virus infection mortality during the first year after allogeneic hematopoietic stem cell transplantation: a prospective epidemiological survey
Bone Marrow Transplantation, Vol. 55, Núm. 2, pp. 431-440
-
Uniform graft-versus-host disease prophylaxis with posttransplant cyclophosphamide, sirolimus, and mycophenolate mofetil following hematopoietic stem cell transplantation from haploidentical, matched sibling and unrelated donors
Bone Marrow Transplantation, Vol. 55, Núm. 11, pp. 2147-2159
2019
-
Clinical Effectiveness of Influenza Vaccination after Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study
Clinical Infectious Diseases, Vol. 68, Núm. 11, pp. 1894-1903
-
Effect of Sirolimus Exposure on the Need for Preemptive Antiviral Therapy for Cytomeglovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation, Vol. 25, Núm. 5, pp. 1022-1030
-
Incidence, risk factors, and outcome of pulmonary invasive fungal disease after respiratory virus infection in allogeneic hematopoietic stem cell transplantation recipients
Transplant Infectious Disease, Vol. 21, Núm. 5
2018
-
Community-acquired respiratory virus lower respiratory tract disease in allogeneic stem cell transplantation recipient: Risk factors and mortality from pulmonary virus-bacterial mixed infections
Transplant Infectious Disease, Vol. 20, Núm. 4
-
Epidemiologic and Clinical Characteristics of Coronavirus and Bocavirus Respiratory Infections after Allogeneic Stem Cell Transplantation: A Prospective Single-Center Study
Biology of Blood and Marrow Transplantation, Vol. 24, Núm. 3, pp. 563-570
-
Sirolimus exposure and the occurrence of cytomegalovirus DNAemia after allogeneic hematopoietic stem cell transplantation
American Journal of Transplantation, Vol. 18, Núm. 12, pp. 2885-2894
2017
-
A risk-adapted approach to treating respiratory syncytial virus and human parainfluenza virus in allogeneic stem cell transplantation recipients with oral ribavirin therapy: A pilot study
Transplant Infectious Disease, Vol. 19, Núm. 4
-
Single umbilical cord blood with or without CD341 cells from a third-party donor in adults with leukemia
Blood Advances, Vol. 1, Núm. 15, pp. 1047-1055